Oaktree Acquisition Corp. III Life Sciences Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing December 16, 2024
Oaktree Acquisition Corp. III Life Sciences (the Company) today announced that, commencing December 16, 2024, holders of the units sold in the Company's initial public offering may elect to...